Loading stock data…
$5.27-0.27 (-4.87%)
DarioHealth Corp.
DarioHealth Corp. in the Healthcare sector is trading at $5.27 with a market capitalization of $68M. Wall Street consensus targets $13.60 (5 analysts), implying a +158.1% move over the next 12 months. The stock is currently near its 52-week low of $5.13, remaining 35.9% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 35/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $5.18M↓ | $5.58M↑ | $5.23M↑ | $5.01M↓ | $5.37M |
| Gross Profit | $3.19M↓ | $3.20M↑ | $2.80M↓ | $3.02M↑ | $2.96M |
| Operating Income | -$6.48M↑ | -$7.31M↑ | -$8.56M↑ | -$9.48M↓ | -$9.20M |
| Net Income | -$7.92M↑ | -$8.25M↑ | -$9.03M↑ | -$10.47M↑ | -$12.99M |
DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching ...